Clinical trial · Observational
Diagnostic Value of C-reactive Protein for Detection of Postoperative Inflammatory Complications After Gastroesophageal Cancer Surgery
NCT01249534CI-TRIAL-00004173completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Although widely used, there is a lack of evidence concerning diagnostic value of C-reactive protein (CRP) in the postoperative course. The aim of this study was to evaluate the diagnostic accuracy of CRP for postoperative inflammatory complications after gastroesophageal cancer.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Given Indication for Gastroesophageal Cancer Surgery | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| gastroesophageal cancer surgery | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Patients after gastroesophageal cancer surgery
- interventionNames
- Other: gastroesophageal cancer surgery
Primary outcomes (1)
- measure
- postoperative Inflammatory complications
- timeFrame
- 30 days postoperatively
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * all patients with gastroesophageal cancer surgery Exclusion Criteria: * lack of measurement of C-reactive protein
References
Publications (0)
Data not yet available
No reference posted for this study.